Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Pediatr Infect Dis J. 2011 Apr;30(4):289–294. doi: 10.1097/INF.0b013e3182002d14

Table 3.

Demographic and Clinical Comparisons by Pathogen

Variable S. pneumoniae serotype

7F (n=21) 19A (n=6) MRSA (n=4) S.pyogenes (n=7)
Demographic Characteristics
Male sex 10 (48%) 4 (67%) 4 (100%) 5 (71%)
Age months, median (range) 43 (17–204) 28 (17–43) 182 (154–198) 90 (24–168)
Preexisting condition 4 (19%) 1 (17%) 2 (50%) 0 (0%)
Admission Characteristics
Illness days, median (range) 7 (3–16) 4.5 (2–7) 4 (2–5) 5 (3–10)
Antibiotic Pretreatment 17 (81%) 5 (83%) 3 (75%) 5 (71%)
Positive Blood or PF culture 8 (38%) 5 (83%) 4 (100%) 3 (43%)
Outcome
LOS days, median (range) 10 (6–49) 11.5 (9–16) 21 (11–32) 11 (4–30)
Hospitalization in ICU 5 (24%) 5 (83%) 2 (50%) 4 (57%)
Dual Infection1 3 (14%) 0 (0%) 1 (25%) 3 (43%)
Death 0 (0%) 0 (0%) 0 (0%) 0 (0%)
1

Dual Infections included: S. pneumoniae and S. pyogenes (2); S. pneumoniae and S. aureus (MSSA; 2); S. pneumoniae and M. pneumoniae (1); S. aureus (MRSA) and S. pyogenes (1)